Owlet Inc. is a leading innovator in infant health technology, dedicated to enhancing the safety and wellness of newborns through its state-of-the-art monitoring solutions. The company's flagship product, the Owlet Smart Sock, employs advanced pulse oximetry to provide parents with real-time insights into their infants' heart rates and oxygen levels via mobile devices. With growing demand for pediatric health monitoring solutions, Owlet is well-positioned to expand its product offerings and fortify its market presence. The company's focus on delivering actionable health information and improving pediatric care aligns with institutional investors' interests in the dynamic health technology sector.
| Revenue (TTM) | $114.41M |
| Gross Profit (TTM) | $62.44M |
| EBITDA | $-7.83M |
| Operating Margin | 5.14% |
| Return on Equity | -526.00% |
| Return on Assets | -6.42% |
| Revenue/Share (TTM) | $4.71 |
| Book Value | $0.80 |
| Price-to-Book | 5.85 |
| Price-to-Sales (TTM) | 1.27 |
| EV/Revenue | 1.283 |
| EV/EBITDA | -0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 29.90% |
| Shares Outstanding | $29.22M |
| Float | $17.61M |
| % Insiders | 10.73% |
| % Institutions | 72.41% |
Volatility is currently contracting
Owlet remains a buy despite flat stock performance, supported by strong Q2 results and ongoing business evolution. Q2 revenue hit a record $33.9M (up 29.9% YoY), with gross margin rebounding to 54% and subscription growth driving margin expansion. Management maintained 2026 guidance, forecasting $120M revenue (13.5% growth) and $8M EBITDA, with international and subscription segments as key growth drivers.
Owlet, Inc. offers the only FDA-approved wearable infant monitor, leveraging patents and data to build a subscription-based telehealth platform. OWLT's pivot to a recurring subscription model targets 1 million users, aiming for higher margins and revenue stability amid ongoing cash burn. Gross margin guidance was raised to 53-55%, with 2026 revenue reaffirmed at $118-$122 million, but near-term profitability remains elusive.
Owlet NYSE: OWLT reported record second-quarter revenue as growth in its connected baby-monitoring products, international markets and subscription business helped offset promotional pressure in the category.
Owlet, Inc. (OWLT) Q2 2026 Earnings Call Transcript
LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) plans to announce second quarter 2026 financial results after market close on Tuesday, August 11, 2026. Owlet's President, Chief Executive Officer, and Co-Founder, Kurt Workman, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-461-5787 (domestic) or 585-542-9983.
Investors need to pay close attention to OWLT stock based on the movements in the options market lately.
LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. today announced that it has entered into a new $25 million asset-based revolving credit facility on June 26, 2026.
Owlet (OWLT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announced today the participation in two upcoming investor conferences. Information on the conferences can be found below. TD Cowen 10th Annual Future of the Consumer Conference William Blair 46th Annual Growth Stock Conference TD Cowen Future of the Consumer Conference Owlet will participate in the TD Cowen 10th Annual Future of the Consumer Conference, taking place on June.
Owlet NYSE: OWLT reported first-quarter 2026 revenue above its own guidance while lowering its full-year sales outlook and raising its profitability forecast, as the baby monitoring and pediatric health technology company said it is narrowing its focus to subscriptions, core markets and operational efficiency.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OWLT and any ticker you trade — then tracks every position and per-strategy win rate.
